Abstract
The number of sphingolipid storage diseases is the object of some disagreement. In Table I, eigh t diseases are delineated. Some researchers classify Sandhoff disease as a separate entity but we consider it a variant form of GM2-gangliosidosis. In our opinion it would be more appropriate to include the fucosidosis in which there is a storage of several neutral fucolipids and probably also of fucose-containing gangliosides (3, 4). The last disease is, in general, included among the oligosaccharidoses in most classification schemes and it is a good example of the difficulty in classifying diseases in which there is a genetic lesion of a lysosomal enzyme. These enzymes have a low degree of specificity and they are generally not specific for a given substance, but act on a certain type of linkage e.g. on a ß-galactosidic linkage in the GM1-gangliosidosis. This linkage can then be localized in a lipid, an oligosaccharide, a glycoprotein or a glycosaminoglycan.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
BRADY, R.O.–The abnormal biochemistry of inherited disorders of lipid metabolism. Fed.Proc., 32: 1660–1667, 1973.
BOWEN, D.M. & RADIN, N.S.–Cerebroside galactosidase: A method for determination and a comparison with other lysosomal enzymes in developing rat brain. J.Neurochem., 16: 501–511, 1969.
DAWSON, G. & TSAY, G.C. - Fucosidosis. In Current Trends in Sphingolipidoses and Allied Disorders,B.W.Volk & L.Schneck (eds.), Advances in Experimental Medicine and Biology, vol. 68, Plenum Press., New York, 1976, pp. 187–203
DURAND, P., BORRONE, C. & DELLACELLA, G.–Fucosidosis. J.Pediat., 75: 665–674, 1969.
FREDRICKSON, D.S. & SLOAN, H.R.–Glucosyl ceramide lipidosis: Gaucher-s Disease. In The Metabolic Basis of Inherited Disease, J.B.Stanbury, J.B.Wyngaarden & D.S.Fredrickson (eds.), Mc GrawHill Book Co., New York, 1972, pp. 730–759.
GALJAARD, H., HOOGEVEEN, A., KEYZER, W., de WIT-VERBEEK, H.A., REUSER, A.J.J., HO, M.W. & ROBINSON, D.–Genetic heterogeneity in different variants of GM1-gangliosidosis studied by ß-galactosidase assays in (single) somatic hybrid cells. Nature (Lond), 257: 60–62, 1975.
HARRIS, H.–The Principles of Human Biochemical Genetics, North-Holland Publishing Co., Amsterdam, 1970, pp. 121–134.
HARTREE, E.F.–Determination of protein. A modification of the Lowry method that gives a linear photometric response. Anal.Biochem., 48: 122–127, 1972.
HIRSCHHORN, K., BERATIS, N.G. & TURNER, B.M.–a-L-Fucosidase in normal and deficient individuals. In Current Trends in Sphingolipidoses and Allied Disorders, B.W.Volk & L.Schneck (eds.), Plenum Press, New York, 1976, pp. 205–223.
HO, M.W.–Identity of “acid” ß-glucosidase and glucocerebrosidase in human spleen. Biochem.J., 136: 721–729, 1973.
JOHANNSEN, W. - Elemente der exakten Erblich Keiblehre, 1909, G.Fischer, Jena.
KABACK, M.M. & 0-BRIEN, J.S.–Tay-Sachs: Prototype for prevention of genetic disease. In Medical Genetics, V.A. Mc Kusick & R. Claiborne (eds.), H.P.Publishing Co. Inc., New York, 1973, pp. 253–262.
KAMPINE. J.P., BRADY, R.O., KANFER, J.N., FELD, M. & SHAPIRO, D.–Diagnosis of Gaucher“s disease and Niemann-Pick disease with small samples of venous blood. Science, 155: 86–88, 1967.
KOLODNY, E.H. & MUMFORD, R.A.–Human leukocyte acid hydro-lases: Characterization of eleven lysosomal enzymes and study of reaction conditions for their automated analysis. Clin.Chim.Acta, 70: 247–257, 1976.
LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R. J.–Protein measurement with the Folin phenol reagent. J.Biol.Chem., 193: 265–275, 1951.
MARTENSON, E., ÖHMAN. R., GRAVES, M. & SVENNERHOLM, L.–Galactosyltransferases catalyzing the formation of the galactosyl-galactosyl linkage in glycosphingolipids. J.Biol. Chem., 249: 4132–4137, 1974.
ÖCKERMAN, P.A. & KöHLIN, P.–Tissue acid hydrolase activities in Gaucher-s disease. Scand.J.Lab.Invest, 22: 62–64, 1968.
SVENNERHOLM, L.–Molecular Neuropathology. In Perspectives in Brain Research, M.A.Corner & D.F.Swaab (eds.), Progr.Brain Research, vol. 45, Elsevier, Amsterdam, 1976, pp. 101–121.
SVENNERHOLM, L., HAKANSSON, G. & VANIER, M.T.–Chemical pathology of Krabbe-s disease. IV. Studies of galactosyl ceramide and lactosylceramide ß-galactosidases in brain, white blood cells and amniotic fluid cells. Acta Paediat.Scand., 64: 649–656, 1975.
TANAKA, H. & SUZUKI, K.–Substrate specificities of the two genetically distinct human brain ß-galactosidases. Brain Res., 122: 325–335, 1977.
TANAKA, H. & SUZUKI, K.–Lactosylceramidase assays for diagnosis of globoid cell leukodystrophy and GM1-gangliosidosis. Clin.Chim.Acta, 75: 267–274, 1977.
VANIER, M.T. & SVENNERHOLM, L.–Chemical pathology of Krabbe disease: The occurrence of psychosine and other neutral sphingoglycolipids. In Current Trends in Sphingolipidoses and Allied Disorders, B.W.Volk & L.Schneck (eds.), Plenum Press, New York, 1976, pp. 115–126.
WENGER, D.A., SATTLER, M., CLARK, C. & MCKELVEY, H.–An improved method for the identification of patients and carriers of Krabbe“s disease. Clin.Chim.Acta, 56: 199–206, 1974.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Press, New York
About this chapter
Cite this chapter
Svennerholm, L. (1978). Diagnoses of the Sphingolipidoses with Labelled Natural Substrates. In: Gatt, S., Freysz, L., Mandel, P. (eds) Enzymes of Lipid Metabolism. Advances in Experimental Medicine and Biology, vol 101. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9071-2_64
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9071-2_64
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9073-6
Online ISBN: 978-1-4615-9071-2
eBook Packages: Springer Book Archive